FAB
SGMO

First American Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

First American Bank’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,215
Closed -$221K – 231
2014
Q1 		$221K Buy
+12,215
New +$235K 0.02% 207

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

First American Bank's SGMO Position: Q2 2014 in Review

First American Bank sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2014, closing a stake of 12,215 shares — an estimated $221K sold.

First American Bank first reported a position in SGMO in Q1 2014 and held it in 1 quarter. The position peaked at $221K in Q1 2014. 156 funds tracked by Wall St. Rank hold SGMO as of Q2 2014.

  • First American Bank reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2014 after selling out during the quarter.
  • First American Bank sold 12,215 SANGAMO THERAPEUTICS INC shares in Q2 2014, an estimated $221K.
  • First American Bank first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 1 quarter.
  • First American Bank's SANGAMO THERAPEUTICS INC position peaked at $221K in Q1 2014.
  • 156 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2014.

Based on First American Bank's 13F filing for Q2 2014, filed 7 Jul 2014.